The ability to develop efficient and versatile technologies for manipulating gene expression is a fundamental issue both in biotechnology and therapeutics. The endogenous RNA interference (RNAi) pathway which mediates gene silencing was discovered at the end of the 20th century and it is nowadays considered as an essential strategy for knockdown of specific genes and for studying gene function. Remarkably, during the past decade, a RNA-induced mechanism of gene activation has also been reported. Likewise RNAi, the RNA activation (RNAa) process is also mediated by sequence-specific double-stranded RNA (dsRNA) molecules, and interesting resemblances between both RNA-based transcriptional mechanisms have been described.
Main text
Over last decade, Li et al. (2006) observed that the introduction of double-stranded RNA (dsRNA) sequences targeting promoter regions of the E-cadherin, VEGF and p21 genes induced gene expression in human cultured cells. Independently, another research group used multiple dsRNAs to target the Transcriptional Start Site (TSS) of the Progesterone Receptor (PR) gene in breast cancer cell lines, obtaining similar results (Janowski et al. 2007) . These examples, and many others, confirmed a targeted, promoterspecific mechanism of gene expression referred to as RNA activation (RNAa). In addition, synthetic dsRNAs targeting sequences beyond the 3' untranslated region of the PR gene were also found to induce RNAa-based activation (Yue et al. 2010) . Although recently discovered, the RNAa mechanism has already shown to be an effective tool to study the expression of cancer-associated genes, being also potentially useful in the design of gain-of-function therapies involving tumor suppressors. For instance, the p21 cyclin-dependent kinase (CDK) inhibitor is a tumor suppressor gene downstream of p53 signaling pathway which modulates cell development by growth inhibition, senescence and differentiation. Accordingly, RNAa-induced p21 expression arrested cell cycle and lead to apoptosis in cancer cells (Yang et al. 2008) . Moreover, the introduction of synthetic dsRNAs designed to target promoter regions of tumor suppressors genes such as KLF4 (Wang et al. 2010 ), WT1, NKX3-1, p53 (Huang et al. 2010 ) and HIC-1 (Pan et al. 2013 ) have been also shown to be able to induce targeted gene expression in mammalian cell lines.
The Figure 1 outlines molecular insights into RNAa and canonical RNA interference (RNAi) pathways. Mechanistically, the core of the RNAa transcriptional machinery includes the Argonaute 2 (Ago2) protein and dsRNAs referred to as small activating RNAs (saRNAs) or antigen RNAs (agRNAs) (Schwartz et al. 2008, Yang et This article is protected by copyright. All rights reserved al. 2008). The saRNAs consist of 21 nucleotides duplexes that are processed by Ago2 and incorporated into the RNA-Induced Transcriptional Activation (RITA) complex also containing the CTR9 and RHA proteins (Portnoy et al. 2016) . CTR9 is a subunit of the PAF1 complex (PAF1C) that regulates initiation and elongation of transcription by interacting with histone-modifying enzymes and RNA polymerase II (RNAP II), whereas RHA is an ATP-dependent DNA/RNA helicase that also recruits chromatin remodelers and factors implicated in formation of the transcriptional activation machinery. Thus, saRNA-Ago2 forms the binary core of the RITA effector complex which associates with heterogeneous nuclear proteins (hnRNPs), transcription factors and RNAP II in order to induce targeted gene expression (Schwartz et al. 2008 , Hu et al. 2012 , Portnoy et al. 2016 ). In addition, a recent work shows that other Argonaute family member, the Argonaute 1 (Ago1) protein, is also required to mediate RNAa-based activation of the Foxg1 gene, a key transcription factor during brain development (Fimiani et al. 2016) .
It is interesting to note that RNAa shares important common features with the RNAi pathway such as the presence of Ago and RHA proteins also known to form part of the RNA-Induced Silencing Complex (RISC); however, the kinetics of both mechanisms are different, being it indicative of distinct signaling processes for each transcriptional pathway. Whereas small interference RNA (siRNA) oligonucleotides induce RNAi in few hours, the response to RNAa treatment is observed only after 2 days following saRNA transfection, with transcriptional effects more durable in the last (RNAa). The most significant resemblances between RNAa and RNAi might include the thermodynamic selectivity of the RNA strand used by Ago2 as guide, and the discovery that certain RNA interference micro-RNAs (miRNAs) targeting promoter regions can also induce activation (Place et al. 2008 , Huang et al. 2012 , Turner et al. 2014 . Likewise
RNAi, the RNAa process triggers epigenetic modifications associated in this case to
This article is protected by copyright. All rights reserved switch-on gene expression (see Fig. 1 ). Recently, the Li laboratory showed that RITA complex recruits chromatin modifying enzymes in order to induce both monoubiquitination of Histone 2B (H2Bub1) and methylation of Histone 3 at Lysine 4 (H3K4me), and subsequent transcriptional elongation by phosphorylation of RNAP II (Portnoy et al. 2016 ). In addition, a decrease in histone acetylation level may also be associated to RNAa (Janowski et al. 2007) . Moreover, in petunia plants, it has been suggested that small dsRNAs derived from regulatory inverted repeat sequences might trigger RNA-directed DNA methylation (RdDM) and thus induce gene expression (Shibuya et al. 2009 ). Taken together, these findings indicate that RNA-based activation phenomena play a role in the establishment and modulation of specific epigenetic pathways.
The RNAa process is a regulatory mechanism encompassing a wide range of animal species and it may be induced by artificially designed saRNAs without need to transfect hazardous macromolecular complexes. Moreover, RNAa also can represent a versatile non-invasive platform for upregulating gene expression in vitro, as well as for overexpressing desired targets in specific tissues and/or developmental stages. In different mammal species, RNAa has been used to selectively activate transcription of essential genes in development (Huang et al 2010) . However, it should be noted that several important characteristics on RNAa molecular functioning must still be elucidated, and further progresses in this area are required to shed light on these questions (Zhao et al. 2015) . It is expected that advances in RNAa research come from genome engineering technologies and especially by programmable nucleases (ZFNs, TALENs and CRISPR/Cas9, etc.) methodological-based approaches for identifying and manipulating saRNAs targeting specific promoters. To conclude, RNAa constitutes a versatile but yet unexplored mechanism that exhibits an interesting potential to activate gene expression,
